ACADIA Pharmaceuticals Inc Dividends
The next dividend date for ACADIA Pharmaceuticals Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for ACADIA Pharmaceuticals Inc (ACAD)
More About ACADIA Pharmaceuticals Inc
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin which completed Phase III clinical trial to treat the negative symptoms of schizophrenia; ACP-101, which completed phase III clinical trial for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 that completed phase II clinical trial for the treatment of Alzheimer's disease psychosis and Lewy Body Dementia with psychosis; ACP-711, which is in phase I clinical trial for the treatment of essential tremor; ACP-211 that is in phase I clinical trial for the treatment of treatment-resistant depression; ACP-2591 that is in Phase I development for Rett syndrome and Fragile X syndrome; and ACP-271, a GPR88 agonist used in evaluation of neurology and is in the IND-enabling stage. The company has a license agreement with Neuren Pharmaceuticals Limited to trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.
Owning ACADIA Pharmaceuticals Inc Stock on the Dividend Date
If you own ACADIA Pharmaceuticals Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of ACADIA Pharmaceuticals Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of ACADIA Pharmaceuticals Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying ACADIA Pharmaceuticals Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the ACADIA Pharmaceuticals Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More ACADIA Pharmaceuticals Inc Dividends
You can contact us any time if you would like to ask questions about ACADIA Pharmaceuticals Inc dividends or anything else related to the stock market.